Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: A southwest oncology group study

Cancer Treatment Reports

Volumn 63, Issue 9-10, 1979, Pages 1557-1564

  Rossof, A H ^a   Talley, R W ^a   Stephens, R ^a   Thigpen, T ^b   Samson, M K ^b   Groppe Jr , C ^b   Eyre, H J ^b   Fisher, R ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVERSE DRUG REACTION; BLADDER; BLADDER CANCER; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER; CANCER CHEMOTHERAPY; DIGESTIVE SYSTEM; FEMALE GENITAL SYSTEM; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC CANCER; HYDRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM; NEPHROTOXICITY; OVARY ADENOCARCINOMA; OVARY CANCER; PROSTATE CANCER; TESTIS CANCER; THERAPY; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER;

CISPLATIN; DIGESTIVE SYSTEM; DRUG EVALUATION; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; KIDNEY; MALE; REMISSION, SPONTANEOUS; UROGENITAL NEOPLASMS;

EID: 0018608637     PISSN: 03615960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)